Inventiva (IVA) Net Cash Flow (2019 - 2025)
Inventiva (IVA) posted quarterly Net Cash Flow of $93.6 million for Q2 2025, up 279.71% year-over-year from $24.6 million in Q2 2024, and up 279.71% quarter-over-quarter from -$52.1 million in Q2 2024.
Analysis
Inventiva (IVA) Net Cash Flow (2019 - 2025) Analysis & Trends
Inventiva's Net Cash Flow history runs 6 years deep, the most recent figure standing at $93.6 million for Q2 2025.
- In Q2 2025, Net Cash Flow rose 279.71% year-over-year to $93.6 million; the TTM figure through Dec 2025 stood at $41.5 million (up 179.71% YoY), while the FY2025 annual figure was $3.7 million, down 94.91% from the prior year.
- Net Cash Flow for Q2 2025 stood at $93.6 million, up from -$52.1 million in the prior quarter.
- The five-year high for Net Cash Flow was $93.6 million in Q2 2025, with the low at -$52.1 million in Q2 2024.
- The 4-year median for Net Cash Flow is -$13.1 million (2022), against an average of -$2.8 million.
- The sharpest annual moves came in 2021 and 2025: Net Cash Flow tumbled 332.96% in 2021, then jumped 279.71% in 2025.
- Inventiva's Net Cash Flow stood at -$17.2 million in 2021, then grew by 25.56% to -$12.8 million in 2022, then sank by 307.0% to -$52.1 million in 2024, then surged by 279.71% to $93.6 million in 2025.
- Business Quant data shows IVA's Net Cash Flow at $93.6 million in Q2 2025, -$52.1 million in Q2 2024, and -$12.8 million in Q4 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 652.90 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -504.30 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -183.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 374.50 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 407.41 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -496,000.00 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 225.59 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -37.14 Mn |
| 10 | Inventiva | 893.85 Mn | 893.85 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | 93.56 Mn |
| Jun 30, 2024 | -52.06 Mn |
| Dec 31, 2022 | -12.79 Mn |
| Sep 22, 2022 | -13.08 Mn |
| Dec 31, 2021 | -17.18 Mn |
| Jun 30, 2021 | -20.66 Mn |
| Mar 31, 2021 | 2.58 Mn |
| Dec 31, 2020 | 19.59 Mn |
| Jun 30, 2020 | 7.03 Mn |
| Mar 31, 2020 | 12.20 Mn |
| Dec 31, 2019 | -21.72 Mn |